PULSE the living trend engine
▲ Peaking Business

Cramer Warns Broadcom’s $30 Billion AI Bet Depends on a Stock You Cannot Buy

2sources
2articles
1velocity
+0%since first seen
1h agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (2)

Related trends

▲ Peaking Business

Summit Packs A Punch For Merck's Keytruda

Summit Therapeutics and Akeso report that their cancer drug ivonescimab clears the overall survival bar in a Phase 3 trial.

5 sources 5 articles v 3 25m ago
\n \n \n \n \n \n \n